-
Hengrui Medicine Carrelizumab: First PD-1 approved for first-line nasopharyngeal carcinoma indication
Time of Update: 2021-07-29
Recently, independent research and development by the Hengrui Medicine PD-1 inhibitors Ka Ruili natalizumab (Erica ® ) was "Drug Registration Certificate" State Drug Administration (NMPA) approval issued by the approval of a single bead Ka Ruili Anti-combined cisplatin and gemcitabine are used for the first-line treatment of patients with locally recurring or metastatic nasopharyngeal carcinoma .
-
A new round of volume procurement is coming!
Time of Update: 2021-07-29
Annual sales trend of terminal chemical drugs in public hospitals in Guangdong Province (unit: 100 million yuan) Source: The terminal competition pattern of public hospitals in key provinces and cities of Meinenet From the perspective of manufacturers' sales structure, the total market share of TOP20 manufacturers exceeds 40% .
-
More than 1,200 scientists approve Britain to unblock irresponsibility as planned
Time of Update: 2021-07-29
The group of experts issued a statement again on the 13th, stating that 1,246 doctors and scientists from all over the world have joined the open letter joint signature, and urged the British government to wait until most people, including minors, have been vaccinated before implementing the unblocking plan .
-
Academician Zhang Bo: The development of brain science helps the new generation of artificial intelligence technology change
Time of Update: 2021-07-29
The root cause is that people know too little about the human brain and intelligence, so the key to the development of a new generation of artificial intelligence lies in the integration of brain science research .
-
WHO passed 6 guidelines including data integrity and pharmaceutical water GMP
Time of Update: 2021-07-29
The suggestions included: Reorganize the content of the "Introduction" section; Add information about "Data Governance", "Data Transmission" and "Computerized Systems"; Expand the content of the "Quality Risk Management Control" section; Clarify the management review system and actions in case of non-compliance; Add a new section "Data Review and Approval"; Improve some examples and make some editorial revisions .
-
With a sales volume of US$1.86 billion in 2020, Roche enmetrastuzumab will soon be approved for new indications in China
Time of Update: 2021-07-29
As the first single-agent ADC approved for the treatment of HER2-positive metastatic breast cancer that has previously received trastuzumab and taxane chemotherapy (alone or in combination), Kadcyla's sales have increased year by year after its launch, reaching 1.
-
18 substances are included in the "Additional Catalogue of Non-medicinal Narcotics and Psychotropic Drugs Controlled Varieties"
Time of Update: 2021-07-29
On May 12, the website of the Ministry of Public Security, the Ministry of Public Security, the National Health Commission and the State Drug Administration jointly issued a joint announcement on the inclusion of 18 substances including synthetic cannabinoids and fluoramine in the "Non-medicinal Narcotics and Psychotropic Drugs" Announcement of the Supplementary Catalogue of Controlled Varieties .
-
Gaofu team's new Zika vaccine "kills two birds with one stone"!
Time of Update: 2021-07-29
" Dai Lianpan said, given the potential long-term effects of Zika virus infection on newborns by pregnant women With serious consequences, it is particularly important to develop a Zika vaccine that can induce a clear immune response in mothers and infants .
-
36 new cases were confirmed on July 15, all imported from abroad
Time of Update: 2021-07-29
As of 24:00 on July 15, according to reports from 31 provinces (autonomous regions and municipalities) and the Xinjiang Production and Construction Corps, there are currently 536 confirmed cases (including 8 severe cases), a total of 87,011 cured and discharged cases, and a total of 4,636 deaths.
-
Cuba's research and development of Latin America's first new crown vaccine has an effective rate of over 92%
Time of Update: 2021-07-29
Havana News: On the 21st local time, the Cuban Biomedical Group announced that its self-developed new crown vaccine "Avdala" has an effective rate of 92.
-
Legendary curtain call!
Time of Update: 2021-07-29
Although as an enterprise with annual sales of nearly 100 billion yuan, Yangtze River Pharmaceutical has not yet been listed.
Xu Jingren also revealed that Yangtze River Pharmaceutical will also invest more than 4 billion yuan in Chinese medicine.
-
Masks that can detect the new coronavirus in the air are coming
Time of Update: 2021-07-29
Science and Technology Daily reporter Zhang Mengran If there is a nucleic acid biosensor that can be embedded in fabrics, can it detect bacteria and viral pathogens in the air, including the new coronavirus?
-
Xin Yuling, a pioneer of thoracic surgery in New China: a hundred-year-old doctor with benevolence and kindness
Time of Update: 2021-07-29
He is Xin Yuling, the Sino-Japanese Friendship Hospital's first president , the cause of thoracic surgery pioneer and founder of New China .
Not long ago, the Xin Yuling Team of the China-Japan Friendship Hospital was formally established .
-
WHO: There may be a more dangerous and difficult to control variant of the new crown virus
Time of Update: 2021-07-29
WHO: A more dangerous and more difficult-to-control variant of the new coronavirus may appear BEIJING, July 16 (Xinhua) reported, the WHO emergency committee will be the 15th issued a statement saying, "The new crown pandemic have not seen the end .
-
Notice on the issuance of errata for the 2020 edition of the Chinese Pharmacopoeia
Time of Update: 2021-07-29
The Drug Administration of all provinces, autonomous regions, and municipalities directly under the Central Government: Since September 2020, the Commission has successively received relevant feedback, and on the basis of a comprehensive review and verification, further corrections have been made to the errors in the editing, proofreading and printing of the Pharmacopoeia .
-
Key mutations may cause cross-species transmission of new coronavirus
Time of Update: 2021-07-29
Liu Xia In the latest study, scientists from Virginia Tech analyzed 182,000 new coronavirus genomes to explore mutations that may help the virus adapt to and spread among humans .
-
WHO releases guidelines for cervical cancer screening, first HPV-DNA test
Time of Update: 2021-07-29
The World Health Organization and the United Nations Special Programme for Human Reproduction jointly issued a new guide on the 6th to help countries better carry out cervical cancer screening and treatment, which recommends HPV-DNA (human papillomavirus-deoxyribonucleic acid) testing As the preferred screening method for cervical cancer screening .
-
Luoxin Pharmaceutical's new indications for ticolasheng tablets are approved to carry out clinical trials
Time of Update: 2021-07-29
(hereinafter referred to as "Luoxin Pharmaceutical") has made significant progress in the research and development of the innovative drug Tigola raw tablets.
-
Popular science: why some people are born immune to the new coronavirus
Time of Update: 2021-07-29
" The summary is as follows: A new study by MedGenome, a genomic data provider, analyzes why some people who are not infected with the new coronavirus and have not been vaccinated are immune to the disease, or at least avoid serious symptoms .
-
New mixed mRNA vaccine is expected to prevent multiple coronaviruses
Time of Update: 2021-07-29
Therefore, the multiple chimeric spike vaccine can prevent the SARS-like zoonotic coronavirus infection that is potentially causing a pandemic .
